SG11202106794WA - Method for treating lower back pain - Google Patents
Method for treating lower back painInfo
- Publication number
- SG11202106794WA SG11202106794WA SG11202106794WA SG11202106794WA SG11202106794WA SG 11202106794W A SG11202106794W A SG 11202106794WA SG 11202106794W A SG11202106794W A SG 11202106794WA SG 11202106794W A SG11202106794W A SG 11202106794WA SG 11202106794W A SG11202106794W A SG 11202106794WA
- Authority
- SG
- Singapore
- Prior art keywords
- lower back
- back pain
- treating lower
- treating
- pain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Developmental Biology & Embryology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962787654P | 2019-01-02 | 2019-01-02 | |
PCT/IB2020/050015 WO2020141473A1 (en) | 2019-01-02 | 2020-01-02 | Method for treating lower back pain |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202106794WA true SG11202106794WA (en) | 2021-07-29 |
Family
ID=69185652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202106794WA SG11202106794WA (en) | 2019-01-02 | 2020-01-02 | Method for treating lower back pain |
Country Status (10)
Country | Link |
---|---|
US (1) | US20220143097A1 (en) |
EP (1) | EP3906035A1 (en) |
JP (1) | JP2022515916A (en) |
KR (1) | KR20210110835A (en) |
CN (1) | CN113631173A (en) |
AU (1) | AU2020204805A1 (en) |
BR (1) | BR112021013158A2 (en) |
CA (1) | CA3125308A1 (en) |
SG (1) | SG11202106794WA (en) |
WO (1) | WO2020141473A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008008774A (en) | 2006-01-13 | 2008-09-26 | Osiris Therapeutics Inc | Mesenchymal stem cells expressing tnf-î± receptor. |
CN112402365B (en) * | 2020-10-26 | 2023-10-03 | 山东博森医学工程技术有限公司 | PRP gel-loaded umbilical cord mesenchymal stem cell composition for treating intervertebral disc degeneration diseases |
KR20230134514A (en) * | 2021-01-22 | 2023-09-21 | 메조블라스트 인터내셔널 에스에이알엘 | Opioid sparing compositions and methods of using the same |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4593089A (en) | 1980-07-30 | 1986-06-03 | Abbott Laboratories | Fluorescent polarization immunoassay utilizing substituted triazinylaminofluorescein aminoglycosides |
US4751190A (en) | 1985-07-22 | 1988-06-14 | Abbott Laboratories | Fluorescence polarization immunoassay and reagents for use therein |
US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
AU8200191A (en) | 1990-07-09 | 1992-02-04 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | High efficiency packaging of mutant adeno-associated virus using amber suppressions |
US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
US5837539A (en) | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
AU663725B2 (en) | 1991-08-20 | 1995-10-19 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Adenovirus mediated transfer of genes to the gastrointestinal tract |
DE4211351A1 (en) | 1992-04-04 | 1993-10-07 | Behringwerke Ag | Method for analyzing particle-enhanced agglutination reactions on centrifugal analyzers by determining the turbidity brightening |
US5670361A (en) | 1993-05-17 | 1997-09-23 | The Regents Of The University Of California | HIV-specific ribozymes |
US6541213B1 (en) | 1996-03-29 | 2003-04-01 | University Of Washington | Microscale diffusion immunoassay |
CA2244326C (en) | 1997-08-11 | 2006-03-28 | Shinichi Eda | Microparticle enhanced light scattering agglutination assay and microparticle reagents therefor |
EP1159611A1 (en) | 1999-01-15 | 2001-12-05 | Medtox Scientific Inc. | Lateral flow test strip |
AU2003901668A0 (en) | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
JP4264348B2 (en) | 2001-08-20 | 2009-05-13 | プロテオム システムズ リミテッド | Diagnostic inspection method and apparatus |
CA2507415A1 (en) | 2002-11-21 | 2004-06-03 | The University Of Leicester | Bodily fluid markers of tissue hypoxia |
US8273347B2 (en) * | 2003-05-13 | 2012-09-25 | Depuy Spine, Inc. | Autologous treatment of degenerated disc with cells |
US20040229878A1 (en) * | 2003-05-13 | 2004-11-18 | Depuy Spine, Inc. | Transdiscal administration of specific inhibitors of P38 kinase |
CN1893962A (en) * | 2003-11-13 | 2007-01-10 | 德普伊斯派尔公司 | Autologous treatment of degenerated disc with cells |
ES2654428T3 (en) | 2005-04-12 | 2018-02-13 | Mesoblast, Inc. | Isolation of adult multipotential cells by non-tissue alkaline phosphatase |
US9598673B2 (en) * | 2006-05-19 | 2017-03-21 | Creative Medical Health | Treatment of disc degenerative disease |
CN105030828B (en) * | 2008-06-25 | 2020-10-02 | 麦瑟布莱斯特公司 | Repair and/or reconstruction of intervertebral discs |
WO2016177805A1 (en) * | 2015-05-05 | 2016-11-10 | Mesoblast International Sàrl | Potency assay |
US20180021380A1 (en) * | 2016-07-21 | 2018-01-25 | Sungkwang Medical Foundation | Composition including mesenchymal stem cell derived from adipose tissues and hyaluronic acid derivative, method of preparing the same, and method of preventing or treating low back pain using the same |
US20180344899A1 (en) * | 2017-06-01 | 2018-12-06 | Creative Medical Technologies, Inc. | Enhancement of nucleus pulposus regeneration by enhanced perfusion of perispinal area by combination drug, gene and cellular therapies |
-
2020
- 2020-01-02 KR KR1020217022383A patent/KR20210110835A/en active Search and Examination
- 2020-01-02 BR BR112021013158-2A patent/BR112021013158A2/en unknown
- 2020-01-02 JP JP2021538792A patent/JP2022515916A/en active Pending
- 2020-01-02 WO PCT/IB2020/050015 patent/WO2020141473A1/en unknown
- 2020-01-02 US US17/420,314 patent/US20220143097A1/en active Pending
- 2020-01-02 EP EP20701503.3A patent/EP3906035A1/en active Pending
- 2020-01-02 AU AU2020204805A patent/AU2020204805A1/en active Pending
- 2020-01-02 CA CA3125308A patent/CA3125308A1/en active Pending
- 2020-01-02 CN CN202080007828.3A patent/CN113631173A/en active Pending
- 2020-01-02 SG SG11202106794WA patent/SG11202106794WA/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2020141473A1 (en) | 2020-07-09 |
CN113631173A (en) | 2021-11-09 |
BR112021013158A2 (en) | 2021-09-14 |
EP3906035A1 (en) | 2021-11-10 |
AU2020204805A1 (en) | 2021-07-29 |
KR20210110835A (en) | 2021-09-09 |
US20220143097A1 (en) | 2022-05-12 |
CA3125308A1 (en) | 2020-07-09 |
JP2022515916A (en) | 2022-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL285496A (en) | Methods for treating cholestasis | |
IL279748A (en) | Composition and method for treating pain | |
IL289301A (en) | Stimulation apparatus | |
IL288201A (en) | Apparatus for treating teeth | |
IL280128A (en) | Method for treating epilepsy | |
IL287907A (en) | Methods for treating cancer | |
SG11202106794WA (en) | Method for treating lower back pain | |
IL285847A (en) | Methods for treating map3k8 positive cancers | |
IL291565A (en) | Methods for treating hyperphenylalaninemia | |
IL288937A (en) | Improved treatment using eyp001 | |
EP4054378C0 (en) | Method for treating the hair | |
IL281792A (en) | Treatment methods | |
IL290770A (en) | Compounds and methods for treating oxalate-related diseases | |
PT3897994T (en) | Method and arrangement for process water treatment | |
IL281839A (en) | Treatment methods | |
ZA202007920B (en) | Laser treatment method | |
ZA202001927B (en) | Method for treating tnf alpha-related diseases | |
IL284629A (en) | Methods for treating ocular surface pain | |
SG11202111960PA (en) | Method for treating endometriosis-associated pain by using diaminopyrimidine compound | |
IL268111A (en) | Methods of treating pain | |
CA195803S (en) | Skin treatment apparatus | |
ZA202101302B (en) | Hair treatment method | |
GB201907065D0 (en) | Surface treatment method | |
GB201910244D0 (en) | Method for treating cancer | |
SG11202103619QA (en) | Methods for treating or preventing skin conditions |